Citizen Health and Rocket Pharma Unite to Transform Patient Outcomes in Rare Cardiomyopathy Treatment Citizen Health's partnership with Rocket Pharma focuses on enhancing drug development and patient experiences in treating PKP2 Cardiomyopathy, a rare heart condition.

Citizen Health and Rocket Pharma Unite to Transform Patient Outcomes in Rare Cardiomyopathy Treatment #USA #San_Francisco #Rocket_Pharma #Citizen_Health #PKP2_Cardiomyopathy

Exploring NYSE's Commitment to Rare Disease Awareness and Market Insights The NYSE highlights its daily pre-market insights and discusses the importance of Rare Disease Day with industry experts. Discover more!

Exploring NYSE's Commitment to Rare Disease Awareness and Market Insights #USA #New_York #New_York_Stock_Exchange #Rare_Disease_Day #Rocket_Pharma